Quadrant Capital Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $897K | Buy |
|
|||||
|
2025
Q2 | $1.08M | Sell |
|
|||||
|
2025
Q1 | $1.62M | Buy |
|
|||||
|
2024
Q4 | $581K | Sell |
|
|||||
|
2024
Q3 | $1.19M | Sell |
|
|||||
|
2024
Q2 | $1.27M | Buy |
|
|||||
|
2024
Q1 | $1.11M | Sell |
|
|||||
|
2023
Q4 | $1.06M | Buy |
|
|||||
|
2023
Q3 | $886K | Buy |
|
|||||
|
2023
Q2 | $900K | Buy |
|
|||||
|
2023
Q1 | $886K | Sell |
|
|||||
|
2022
Q4 | $1.15M | Buy |
|
|||||
|
2022
Q3 | $937K | Sell |
|
|||||
|
2022
Q2 | $998K | Buy |
|
|||||
|
2022
Q1 | $993K | Buy |
|
|||||
|
2021
Q4 | $862K | Sell |
|
|||||
|
2021
Q3 | $829K | Buy |
|
|||||
|
2021
Q2 | $703K | Buy |
|
|||||
|
2021
Q1 | $639K | Buy |
|
|||||
|
2020
Q4 | $523K | Buy |
|
|||||
|
2020
Q3 | $421K | Sell |
|
|||||
|
2020
Q2 | $427K | Sell |
|
|||||
|
2020
Q1 | $838K | Buy |
|
|||||
|
2019
Q4 | $572K | Buy |
|
|||||
|
2019
Q3 | $321K | Sell |
|
|||||
|
2019
Q2 | $563K | Sell |
|
|||||
|
2019
Q1 | $620K | Buy |
|
|||||
|
2018
Q4 | $376K | Buy |
|
|||||
|
2018
Q3 | $393K | Buy |
|
|||||
|
2018
Q2 | $326K | Sell |
|
|||||
|
2018
Q1 | $307K | Buy |
|
|||||
|
2017
Q4 | $307K | Buy |
|
|||||
|
2017
Q3 | $255K | Buy |
|
|||||
|
2017
Q2 | $221K | Sell |
|
|||||
|
2017
Q1 | $245K | Buy |
|
|||||
|
2016
Q4 | $202K | Buy |
|
|||||
|
2016
Q3 | $157K | Buy |
|
|||||
|
2016
Q2 | $149K | Sell |
|
|||||
|
2016
Q1 | $175K | Buy |
|
|||||
|
2015
Q4 | $162K | Buy |
|
|||||
|
2015
Q3 | $162K | Sell |
|
|||||
|
2015
Q2 | $193K | Buy |
|